◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksW › WEED

Canopy Growth Corporation (WEED) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-16

Canopy Growth Corporation (WEED) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Smiths Falls, Canada with about 1,128 employees. Its market capitalization is roughly CAD 619 million. In the fiscal year ended 2026-03-31, WEED reported CAD 285M in revenue and (CAD 263M) in net income.

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.

Interactive charts & full statements →

WEED Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-312022-03-31
Total RevenueCAD 285MCAD 269MCAD 297MCAD 333M
Gross ProfitCAD 70MCAD 80MCAD 81M(CAD 64M)
Operating Income (EBIT)(CAD 73M)(CAD 66M)(CAD 163M)(CAD 396M)
Net Income(CAD 263M)(CAD 509M)(CAD 694M)(CAD 3.3B)

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WEED Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total RevenueCAD 81MCAD 71MCAD 74MCAD 67MCAD 72M
Gross ProfitCAD 22MCAD 8MCAD 22MCAD 22MCAD 18M
Operating Income (EBIT)(CAD 18M)(CAD 28M)(CAD 13M)(CAD 15M)(CAD 18M)
Net Income(CAD 15M)(CAD 157M)(CAD 63M)(CAD 2M)(CAD 45M)

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WEED Free Cash Flow History

WEED Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total AssetsCAD 1.1BCAD 918MCAD 1.3BCAD 2.4B
Total LiabilitiesCAD 421MCAD 439MCAD 900MCAD 1.7B

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WEED viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← WECAll “W” companiesWEF →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.